AlphaCentric Advisors LLC
- SEC CIK
- 0001913464
- Latest filing
- Jul 24, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 13, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 234
- +3 vs. Q2 2023
- Portfolio value
- $176.2M
- −$3.88M (−2.2%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| COOPMaverick Merger Sub 2, LLC | COM | 31,290 | $1.68M | 1.0% | −10,000−24.2% | Reduced | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 132,000 | $1.68M | 1.0% | +54,500+70.3% | Added | History |
| ADAMAdamas Trust, Inc. | COM | 200,963 | $1.71M | 1.0% | +15,000+8.1% | Added | History |
| GSKGSK plc | ADR | 50,000 | $1.81M | 1.0% | 00.0% | Unchanged | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 110,000 | $1.91M | 1.1% | 00.0% | Unchanged | History |
| Pennymac Corp70932AAD5 | NOTE 5.500%11/0 | 1,965,000 | $1.92M | 1.1% | 00.0% | Unchanged | – |
| MFAMfa Financial, Inc. | COM | 202,725 | $1.95M | 1.1% | +15,000+8.0% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 80,000 | $2.02M | 1.1% | −15,000−15.8% | Reduced | History |
| UTHRUnited Therapeutics Corp | COM | 9,000 | $2.03M | 1.2% | 00.0% | Unchanged | History |
| RWT Hldgs Inc749772AD1 | CONVERTIBLE BOND | 2,284,000 | $2.12M | 1.2% | 00.0% | Unchanged | – |
| iShares Russell 1000 Value ETF464287598 | ETF | 14,193 | $2.15M | 1.2% | −812−5.4% | Reduced | – |
| Invesco Exchange Traded FD T46137V258 | S&P500 PUR VAL | 29,285 | $2.15M | 1.2% | −1,926−6.2% | Reduced | – |
| DXDynex Capital Inc | COM | 181,492 | $2.17M | 1.2% | +28,000+18.2% | Added | History |
| RVNCRevance Therapeutics, Inc. | COM | 190,000 | $2.18M | 1.2% | +190,000 | New | History |
| URGNUroGen Pharma Ltd. | COM | 165,000 | $2.31M | 1.3% | +12,500+8.2% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 82,000 | $2.44M | 1.4% | +35,000+74.5% | Added | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 657,500 | $2.58M | 1.5% | +477,500+265.3% | Added | History |
| QUREuniQure N.V. | SHS | 391,500 | $2.63M | 1.5% | +344,000+724.2% | Added | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 145,500 | $2.66M | 1.5% | +37,500+34.7% | Added | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 292,500 | $2.82M | 1.6% | +135,000+85.7% | Added | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 25,500 | $2.95M | 1.7% | 00.0% | Unchanged | History |
| Two HBRS Invt Corp90187BAB7 | NOTE 6.250% 1/1 | 3,205,000 | $2.96M | 1.7% | +1,000,000+45.4% | Added | – |
| EFCEllington Financial Inc. | COM | 239,271 | $2.98M | 1.7% | 00.0% | Unchanged | History |
| EMBCEmbecta Corp. | Stock | 207,000 | $3.12M | 1.8% | +113,500+121.4% | Added | History |
| PCRXPacira BioSciences, Inc. | COM | 103,000 | $3.16M | 1.8% | +46,500+82.3% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 30,000 | $3.38M | 1.9% | −6,500−17.8% | Reduced | History |
| CHRSCoherus Oncology, Inc. | COM | 912,500 | $3.41M | 1.9% | 00.0% | Unchanged | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 26,500 | $3.43M | 1.9% | −14,250−35.0% | Reduced | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 105,000 | $3.63M | 2.1% | +6,000+6.1% | Added | History |
| iShares Tr464287457 | 1 3 YR TREAS BD | 45,190 | $3.66M | 2.1% | +18,397+68.7% | Added | – |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 122,000 | $4.00M | 2.3% | +4,000+3.4% | Added | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 649,000 | $4.59M | 2.6% | +79,000+13.9% | Added | History |
| RITMRithm Capital Corp. | REIT | 507,277 | $4.71M | 2.7% | +15,578+3.2% | Added | History |
| WBAWalgreens Boots Alliance, Inc. | COM | 225,000 | $5.00M | 2.8% | +145,000+181.3% | Added | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| URIUnited Rentals, Inc. | COM | – | $137.8K |
Sold out since Q2 2023 (21)
Positions held at the end of Q2 2023 that are gone from this filing.
| Security | Class | Shares in Q2 2023 | Value in Q2 2023 | % of portfolio in Q2 2023 | History |
|---|---|---|---|---|---|
| AHCOAdaptHealth Corp. | COMMON STOCK | 282,500 | $3.44M | 1.9% | History |
| ELANElanco Animal Health Inc | COM | 295,000 | $2.97M | 1.6% | History |
| CNCCentene Corp | Stock | 40,000 | $2.70M | 1.5% | History |
| iShares Tr464288588 | MBS ETF | 21,955 | $2.05M | 1.1% | – |
| LNTHLantheus Holdings, Inc. | Stock | 23,000 | $1.93M | 1.1% | History |
| FLGTFulgent Genetics, Inc. | COM | 39,000 | $1.44M | 0.8% | History |
| WELLWelltower Inc. | REIT | 11,059 | $894.6K | 0.5% | History |
| ITOSiTeos Therapeutics, Inc. | COM | 63,000 | $834.1K | 0.5% | History |
| iShares Tr464288661 | 3 7 YR TREAS BD | 6,920 | $797.6K | 0.4% | – |
| NLYAnnaly Capital Management Inc | REIT | 37,500 | $750.4K | 0.4% | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 585,000 | $696.1K | 0.4% | History |
| iShares Inc464286103 | MSCI AUST ETF | 23,064 | $520.1K | 0.3% | – |
| DHIHorton D R Inc | COM | 3,000 | $365.1K | 0.2% | History |
| RBOTVicarious Surgical Inc. | COM CL A | 175,000 | $320.3K | 0.2% | History |
| EQRXEQRx, Inc. | COM | 80,000 | $148.8K | 0.1% | History |
| iShares Inc464286640 | MSCI CHILE ETF | 4,932 | $143.9K | 0.1% | – |
| iShares Tr46429B309 | MSCI INDONIA ETF | 5,961 | $137.4K | 0.1% | – |
| iShares Inc464286814 | MSCI NETHERL ETF | 2,959 | $128.1K | 0.1% | – |
| iShares Inc464286756 | MSCI SWEDEN ETF | 3,608 | $127.8K | 0.1% | – |
| iShares Iboxx $ Investment Grade Corporate Bond ETF464287242 | ETF | 779 | $84.2K | <0.1% | – |
| SPDR Series Trust78464A490 | ST STR FTSE ETF | 1,848 | $77.2K | <0.1% | – |